The results of this study indicated that miR-145-5p could repress the proliferation, migration, and invasion of NPC cells via KLF5/FAK regulation, and could be a potential therapeutic target for patients with NPC. The gene discussed is PTK2; the disease is nasopharyngeal carcinoma.